Ozempic Seeking High Dose OK; Thyroid Cancer Overdiagnosed in Kids?



(MedPage Today) — Novo Nordisk filed for FDA approval of its once-weekly GLP-1 receptor agonist Ozempic (semaglutide) at a higher dose of 2.0 mg. It’s currently available in 0.5-mg and 1-mg injectable dosing. (FiercePharma)
A small study found…

Source link

Comments are closed, but trackbacks and pingbacks are open.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy